The Dawn of Earthquake Prediction Research in China: A Case Study of Seismic Activity in the Tianshan Mountains
Chinese Earth Sciences Review · 2024
DOI: 10.48014/cesr.20240329002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Earth Sciences Review, 2024. Verfasst von Lijun CHEN. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
The paper adopts the Unified Earthquake Catalog of China and according to the Chen Lijun's Seismo-geothermcs and its working method, and studies the planar and three-dimensional distribution images, sequential processes, abnormal states in the last two years, the background of historical seismic activity and the influence of seismic cone tectonic environment in the Tianshan Mountains. In this paper, with reference to the author's experience in the global case study of intracrustal strong seismic activity, it is believed that the seismic geothermal anomaly of the Nantianshan seismic sub-seismic cone tectonic can be confirmed without error, so it is speculated that the intracrustal strong seismic activity of M6. 5-7 may occur in Aksu area in the next 1-2 years in the tectonic influence area, which is worthy of high vigilance and close attention. This strong earthquake prediction opinion has been verified by the M7. 1 earthquake in Aksu, Xinjiang on January 23, 2024, which deserves affirmation.
Zitieren
APA
CHEN, L. (2024). The Dawn of Earthquake Prediction Research in China: A Case Study of Seismic Activity in the Tianshan Mountains. Chinese Earth Sciences Review. https://doi.org/10.48014/cesr.20240329002
Vancouver
CHEN L. The Dawn of Earthquake Prediction Research in China: A Case Study of Seismic Activity in the Tianshan Mountains. Chinese Earth Sciences Review. 2024. doi:10.48014/cesr.20240329002
BibTeX
@article{CHEN2024,
author = {CHEN, Lijun},
title = {The Dawn of Earthquake Prediction Research in China: A Case Study of Seismic Activity in the Tianshan Mountains},
journal = {Chinese Earth Sciences Review},
year = {2024},
doi = {10.48014/cesr.20240329002}
}
EUVIMED